Utilization patterns of the COVID-19 mRNA vaccine (Comirnaty®) from the VAC4EU active safety surveillance study in five European countries

Alejandro Arana; Rachel Weinrib; Xabier Garcia de Albeniz Martinez; Daniel Weibel; Cynthia de Luise; Roel J. H. Elbers; Rutger van den Bor; Ivonne Martin; Albert Cid-Royo; Estel Plana; Xabier Garcia de Albeniz Martinez; Rachel Weinrib; Natasha Yefimenko; Beatriz Poblador-Plou; Ettore Marconi; Elisa Barbieri; Luca Stona; Karin M. A. Swart; Debabrata Roy; Giulia Hyeraci; Claudia Bartolini; Angela Lupattelli; Felipe Villalobos; Katherine Kendrick; Renu Garg; Heather Rubino; Rene Eijkemans; Miriam C J M Sturkenboom; Alejandro Arana

Utilization patterns of the COVID-19 mRNA vaccine (Comirnaty®) from the VAC4EU active safety surveillance study in five European countries

Weibel, D., de Luise, C., Elbers, R. J. H., van den Bor, R., Martin, I., Cid-Royo, A., Plana, E., Martinez, X. G. D. A., Weinrib, R., Yefimenko, N., Poblador-Plou, B., Marconi, E., Barbieri, E., Stona, L., Swart, K. M. A., Roy, D., Hyeraci, G., Bartolini, C. C., Lupattelli, A., ... Arana, A. (2023). Utilization patterns of the COVID-19 mRNA vaccine (Comirnaty®) from the VAC4EU active safety surveillance study in five European countries. Pharmacoepidemiology and Drug Safety, 32, 173-174.

Copy citation